News

Gillian Meek Takes the Helm as Bauer Hockey's New EVP

Gillian Meek Takes the Helm as Bauer Hockey's New EVP

Gillian Meek Takes the Helm at Bauer Hockey

Bauer Hockey, renowned as the leading manufacturer of hockey equipment, recently announced the appointment of Gillian Meek as its new Executive Vice President and General Manager. This announcement highlights the company’s commitment to innovation and consumer-focused strategies as it gears up for the future.

Meek's Impressive Background

With over twenty years of experience in executive leadership and global brand management, Gillian Meek brings a wealth of knowledge to Bauer Hockey. Before this role, she served as CEO of Kamik Canada, Inc., where she successfully developed a team and an effective growth plan centered on consumer needs and marketing. Her impressive ability to navigate market challenges and drive profitability makes her a valuable asset for the Bauer team.

A Track Record of Success

Prior to her tenure at Kamik, Gillian was the Global President of Keds, where she was instrumental in revitalizing the brand. She drove significant profitability and expanded its reach into new international markets, showcasing her skills in leadership and strategic positioning. With experience across major brands such as Wolverine Worldwide, Stride Rite, and Timberland, Gillian’s impact on the industry is profound.

A Vision for the Future

In her new role, Meek will oversee the Bauer brand and business operations, focusing on strategy development and execution. Ed Kinnaly, CEO of Peak Achievement Athletics, expressed excitement about Meek’s appointment, highlighting her experience and alignment with the core values of Bauer Hockey, which prioritize teamwork and consumer satisfaction.

Embracing Bauer’s Legacy

As she steps into this pivotal role, Gillian reflects on the strong heritage of Bauer Hockey, a brand that's been enhancing performance and protection for nearly 100 years. She has expressed her eagerness to drive innovation across Bauer’s product lines, ranging from equipment to marketing initiatives, and to continue the legacy of excellence that defines the brand.

Educational Credentials

Gillian Meek holds an MBA from Babson College and an undergraduate degree in finance and economics from Western University. Her solid educational foundation complements her extensive practical experience, as she begins her new journey with Bauer Hockey.

About Bauer Hockey

Bauer Hockey stands at the forefront of hockey equipment design, marketing, and manufacturing. Established in 1927 in Kitchener, Ontario, the brand redefined the game with the introduction of the first skate featuring a blade attached to a boot. Since then, Bauer has been at the cutting edge of hockey gear innovation. The brand is known for its widely popular lines, including SUPREME®, VAPOR®, and NEXUS®, which continue to be favorites among athletes worldwide.

Frequently Asked Questions

What is the significance of Gillian Meek's appointment?

Gillian Meek’s appointment as EVP & General Manager of Bauer Hockey signifies a strategic move to strengthen leadership and enhance brand innovation, building on a century of excellence in hockey equipment.

What previous experience does Gillian Meek have?

Before joining Bauer Hockey, Gillian Meek served as CEO of Kamik Canada, Inc., and has held significant roles at Keds, Wolverine Worldwide, Stride Rite, and Timberland.

How long has Bauer Hockey been in operation?

Bauer Hockey was founded in 1927, making it one of the oldest and most established brands in the hockey equipment industry.

What is the focus of Bauer Hockey under Gillian's leadership?

Under Gillian Meek’s leadership, Bauer Hockey aims to enhance innovation in product development and strengthen its commitment to team and consumer needs.

Where is Bauer Hockey headquartered?

Bauer Hockey’s corporate office is based in Exeter, New Hampshire, where it continues its legacy of designing and manufacturing top-tier hockey equipment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 2

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 0

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
Solomon e3 Halves Cloud Costs with NexQloud Shift

Updated Category News Views 3

Ever feel like you're drowning in an unnecessary cloud bill? Well, Solomon e3 did something about it. They chopped over half of their cloud spending after partnering with NexQloud. This isn't just an old-school belt-tightening; it's a full-on digital revamp after a deep-dive into their IT finances. Saving Pennies and Dollars with Smart Moves You'd think an energy company...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Innovative SOV Launches for Offshore Wind Revolution

Updated Category News Views 2

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 2

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 3

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Patti Humble Joins EWA, Strengthens Female Leadership

Updated Category News Views 1

Strengthening the Network: Patti Humble Joins EWA Seeing Patti Humble lace up her boots and march into the Exceptional Women Alliance (EWA) is like watching a seasoned chess master find her tournament. Over decades, Humble's built a reputation as a linchpin in the corporate finance world, weathering transformations, mergers, and industry shifts that'd make a lesser-known...

Continue Reading
Vobile Teams Up with UNN for AI Factories in Brunei

Updated Category News Views 3

Delving into Vobile's Latest Strategic Move Vobile, a heavyweight in digital content protection based out of Santa Clara, California, has hit the headlines with a new venture. They've inked a strategic cooperation and commercial agreements with Unified National Networks (UNN) of Brunei Darussalam to construct AI factories. This ain't your run-of-the-mill news, folks. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals Moves Ahead with Promising Alzheimer's Study

Updated Category News Views 152

Acumen Pharmaceuticals Shares Phase 1 Study Insights on Alzheimer’s Treatment In recent news, Acumen Pharmaceuticals is making significant strides in its commitment to tackling early Alzheimer’s disease (AD) with its investigational drug, sabirnetug (ACU193). The Phase 1 INTERCEPT-AD study has garnered attention after its findings were published in a renowned journal...

Continue Reading
Exploring the Future of the Prosthetics and Orthotics Market

Updated Category News Views 133

Exploring the Growth of the Prosthetics and Orthotics Market The prosthetics and orthotics market is undergoing a remarkable change, with projections indicating growth from USD 9.04 billion in 2023 to USD 14.23 billion by 2033. This results in a compound annual growth rate (CAGR) of 4.64%. As the industry responds to the rising demand for personalized solutions stemming...

Continue Reading
Atea Pharmaceuticals: Key Insights Ahead of Earnings Release

Updated Category News Views 154

Atea Pharmaceuticals: Key Insights Ahead of Earnings Release Atea Pharmaceuticals (NASDAQ: AVIR) is on the verge of announcing its quarterly earnings, and investors are gearing up for this significant event. As anticipation builds, it’s crucial to understand the implications surrounding earnings disclosures and what they might mean for the company and its shareholders....

Continue Reading
Expanding Cloud Managed Services Market: Trends and Insights

Updated Category News Views 169

Exploring the Cloud Managed Services Market Growth The cloud managed services market is experiencing remarkable growth as businesses embrace digital modernization and optimize their IT operations. Valued at approximately USD 140.96 billion in recent reports, projections suggest that by 2030, this market could soar to around USD 222.81 billion, reflecting a compound annual...

Continue Reading
Brookfield Asset Management Posts Stellar Q3 Performance

Updated Category News Views 35

Brookfield Asset Management Reports Remarkable Q3 Earnings Brookfield Asset Management Ltd. (NYSE: BAM) has recently unveiled its impressive financial results for the third quarter. This quarter was marked by a remarkable achievement in fee-related earnings reaching $644 million, reflecting a year-over-year increase of 14%. Significant Increase in Fee-Bearing Capital...

Continue Reading